Kathleen Kemmer

Assistant Professor

  • 781 Citations
  • 6 h-Index
20032019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2003 2019

  • 781 Citations
  • 6 h-Index
  • 8 Article
  • 1 Comment/debate
  • 1 Review article
2019
1 Citation (Scopus)

Early Prediction of Breast Cancer Therapy Response using Multiresolution Fractal Analysis of DCE-MRI Parametric Maps

Machireddy, A., Thibault, G., Tudorica, L. A., Afzal, A., Mishal, M., Kemmer, K., Naik, A., Troxell, M., Goranson, E., Oh, K., Roy, N., Jafarian, N., Holtorf, M., Huang, W. & Song, X., Mar 1 2019, In : Tomography (Ann Arbor, Mich.). 5, 1, p. 90-98 9 p.

Research output: Contribution to journalArticle

Open Access
Fractals
Magnetic Resonance Imaging
Breast Neoplasms
Drug Therapy
Area Under Curve
2018
Axilla
Manuscripts
Clinical Trials
Breast Neoplasms
Jasminum
Oncology
Biopsy
Genes
Tumors
Testing
2 Citations (Scopus)

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint

and I-SPY 2 Investigators, Dec 1 2018, In : npj Breast Cancer. 4, 1, 26.

Research output: Contribution to journalReview article

Axilla
Clinical Trials
Breast Neoplasms
Lymph Node Excision
Drug Therapy
2017
125 Citations (Scopus)
Placebos
Breast Neoplasms
Disease-Free Survival
Therapeutics
Diarrhea
2016
121 Citations (Scopus)

Adaptive randomization of neratinib in early breast cancer

the I-SPY 2 Investigators, Jul 7 2016, In : New England Journal of Medicine. 375, 1, p. 11-22 12 p.

Research output: Contribution to journalArticle

Random Allocation
Breast Neoplasms
Biomarkers
Hormones
Neoadjuvant Therapy
191 Citations (Scopus)

Adaptive randomization of veliparib-carboplatin treatment in breast cancer

the I-SPY 2 Investigators, Jul 7 2016, In : New England Journal of Medicine. 375, 1, p. 23-34 12 p.

Research output: Contribution to journalArticle

Carboplatin
Random Allocation
Breast Neoplasms
Biomarkers
Triple Negative Breast Neoplasms
36 Citations (Scopus)

Early prediction and evaluation of breast cancer response to neoadjuvant chemotherapy using quantitative DCE-MRI

Tudorica, L. A., Oh, K., Chui, S. S., Roy, N., Troxell, M., Naik, A., Kemmer, K., Chen, Y., Holtorf, M. L., Afzal, A., Springer, C. J., Li, X. & Huang, W., Feb 1 2016, In : Translational Oncology. 9, 1, p. 8-17 10 p.

Research output: Contribution to journalArticle

Magnetic Resonance Imaging
Breast Neoplasms
Drug Therapy
Residual Neoplasm
Neoplasms
2004
256 Citations (Scopus)

KIT Mutations are Common in Testicular Seminomas

Kemmer, K., Corless, C., Fletcher, J. A., McGreevey, L., Haley, A., Griffith, D., Cummings, O. W., Wait, C., Town, A. & Heinrich, M., Jan 2004, In : American Journal of Pathology. 164, 1, p. 305-313 9 p.

Research output: Contribution to journalArticle

Seminoma
Mutation
Dysgerminoma
Stem Cell Factor
Phosphatidylinositol 3-Kinase
2003
49 Citations (Scopus)

Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors

Madani, A., Kemmer, K., Sweeney, C., Corless, C., Ulbright, T., Heinrich, M. & Einhorn, L., Jun 1 2003, In : Annals of Oncology. 14, 6, p. 873-880 8 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Germ Cell and Embryonal Neoplasms
Drug Therapy
Exons
Confidence Intervals